Dr. Berman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Milstein 9 Garden North
177 Fort Washington Avenue
New York, NY 10032Phone+1 212-305-3090Fax+1 212-305-4724
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Psychiatry, 2000 - 2004
University of Pittsburgh School of MedicineClass of 2000
Certifications & Licensure
NY State Medical License 2001 - 2025- American Board of Psychiatry and Neurology Psychiatry
Publications & Presentations
PubMed
- 2595 citationsAntidepressant effects of ketamine in depressed patientsRobert M. Berman, Angela Cappiello, Amit Anand, Dan A. Oren, George R. Heninger
Biological Psychiatry. 2000-02-15 - 315 citationsIncreased cortical GABA concentrations in depressed patients receiving ECT.Gerard Sanacora, Graeme F. Mason, Douglas L. Rothman, Fahmeed Hyder, James J. Ciarcia
The American Journal of Psychiatry. 2003-03-01 - 203 citationsNMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disordersJohn H. Krystal, D. Cyril D’Souza, Ismene L. Petrakis, Aysenil Belger, Robert M. Berman
Harvard Review of Psychiatry. 1999-01-01
Press Mentions
Positive 3-Year VenoValve(R) First-in-Human Data Presented at 49th Annual VEITH Symposium on Vascular and Endovascular IssuesNovember 17th, 2022- Envveno Medical Reports Successful Completion of First VenoValve Surgery for US Pivotal TrialOctober 26th, 2021
Fast-Acting Depression Drug, Newly Approved, Could Help MillionsMarch 6th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
